欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
DK/H/3096/003
药品名称
Cresnisol
活性成分
alanine 16.0 g/l
arginine 10.9 g/l
aspartic acid 3.2 g/l
glutamic acid 5.53 g/l
glycine 7.68 g/l
histidine 6.6 g/l
isoleucine 5.53 g/l
leucine 7.68 g/l
lysine 8.64 g/l
methionine 5.53 g/l
phenylalanine 7.68 g/l
proline 6.6 g/l
serine 4.38 g/l
threonine 5.53 g/l
tryptophan 1.85 g/l
tyrosine 0.28 g/l
valine 7.08 g/l
剂型
Solution for infusion
上市许可持有人
Baxter A/S Tobaksvejen 2 A 2860 Søborg Denmark
参考成员国 - 产品名称
Denmark (DK)
Cresnisol
互认成员国 - 产品名称
United Kingdom (Northern Ireland) (XI)
Ireland (IE)
France (FR)
Spain (ES)
Germany (DE)
Flosol 11,1 % Infusionslösung
许可日期
2021/01/13
最近更新日期
2023/12/29
药物ATC编码
B05BA01 amino acids
申请类型
TypeLevel1:
Known Active Substance
TypeLevel2:
Additional Strength/Form
TypeLevel3:
Bibliographic Art 10 a Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final SPC
|
common-spc-cresnisol-wolytes-20210112
Date of last change:2021/10/06
Final PL
|
common-pl-cresnisol-wolytes-20210112
Date of last change:2021/10/06
Final Labelling
|
common-interpack-cresnisol-n10-20210112
Date of last change:2021/10/06
Final Labelling
|
common-interpack-cresnisol-n24-20210112
Date of last change:2021/10/06
Final Labelling
|
common-interpack-cresnisol-n18-20210112
Date of last change:2021/10/06
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase